Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2002Journal of Viral Hepatitis

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

View Full Paper
Ask AI
Bookmark
Share

Authors

TPThierry PoynardDélégation Paris 5FIFrançoise Imbert‐BismutSorbonne UniversitéVRVlad RatziuUniversité Claude Bernard Lyon 1

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Poynard et al. (2002) studied this question.

synapsesocial.com/papers/6a81f83fb35cb7638cee3e91https://doi.org/10.1046/j.1365-2893.2002.00341.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy2000 · 739 citations
  2. 2Appropriateness of Liver Biopsy2000 · 192 citations
  3. 3The inconvenience of investigations used in hepatology: patients' and hepatologists' opinions1982 · 12 citations
  4. 4Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis C1994 · 2,010 citations
  5. 5Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection1998 · 128 citations